CLLS
Price
$2.68
Change
+$0.05 (+1.90%)
Updated
Sep 5 closing price
Capitalization
267.21M
65 days until earnings call
SLN
Price
$5.69
Change
+$0.46 (+8.80%)
Updated
Sep 5 closing price
Capitalization
226.72M
72 days until earnings call
Interact to see
Advertisement

CLLS vs SLN

Header iconCLLS vs SLN Comparison
Open Charts CLLS vs SLNBanner chart's image
Cellectis SA
Price$2.68
Change+$0.05 (+1.90%)
Volume$55K
Capitalization267.21M
Silence Therapeutics
Price$5.69
Change+$0.46 (+8.80%)
Volume$66.68K
Capitalization226.72M
CLLS vs SLN Comparison Chart in %
Loading...
CLLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CLLS vs. SLN commentary
Sep 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLLS is a StrongBuy and SLN is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 07, 2025
Stock price -- (CLLS: $2.68 vs. SLN: $5.69)
Brand notoriety: CLLS and SLN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CLLS: 29% vs. SLN: 94%
Market capitalization -- CLLS: $267.21M vs. SLN: $226.72M
CLLS [@Biotechnology] is valued at $267.21M. SLN’s [@Biotechnology] market capitalization is $226.72M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLLS’s FA Score shows that 1 FA rating(s) are green whileSLN’s FA Score has 1 green FA rating(s).

  • CLLS’s FA Score: 1 green, 4 red.
  • SLN’s FA Score: 1 green, 4 red.
According to our system of comparison, CLLS is a better buy in the long-term than SLN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLLS’s TA Score shows that 3 TA indicator(s) are bullish while SLN’s TA Score has 7 bullish TA indicator(s).

  • CLLS’s TA Score: 3 bullish, 3 bearish.
  • SLN’s TA Score: 7 bullish, 4 bearish.
According to our system of comparison, SLN is a better buy in the short-term than CLLS.

Price Growth

CLLS (@Biotechnology) experienced а +4.16% price change this week, while SLN (@Biotechnology) price change was +18.30% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.52%. For the same industry, the average monthly price growth was +14.48%, and the average quarterly price growth was +31.71%.

Reported Earning Dates

CLLS is expected to report earnings on Nov 10, 2025.

SLN is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+2.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CLLS($267M) has a higher market cap than SLN($227M). CLLS YTD gains are higher at: 48.889 vs. SLN (-17.297). CLLS has higher annual earnings (EBITDA): -30.25M vs. SLN (-84.82M). CLLS has more cash in the bank: 196M vs. SLN (114M). SLN has less debt than CLLS: SLN (0) vs CLLS (94.8M). CLLS has higher revenues than SLN: CLLS (56.3M) vs SLN (27.2M).
CLLSSLNCLLS / SLN
Capitalization267M227M118%
EBITDA-30.25M-84.82M36%
Gain YTD48.889-17.297-283%
P/E RatioN/AN/A-
Revenue56.3M27.2M207%
Total Cash196M114M172%
Total Debt94.8M0-
FUNDAMENTALS RATINGS
CLLS: Fundamental Ratings
CLLS
OUTLOOK RATING
1..100
77
VALUATION
overvalued / fair valued / undervalued
1..100
30
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CLLSSLN
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
84%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
83%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
77%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
68%
Bullish Trend 2 days ago
86%
Advances
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
88%
Declines
ODDS (%)
Bearish Trend 9 days ago
89%
Bearish Trend 5 days ago
89%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
84%
Aroon
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
CLLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SLN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RSAU0.280.09
+48.51%
Rooshine Inc.
IMBBY42.260.49
+1.17%
Imperial Brands PLC
VTEPF0.63N/A
N/A
VIDENDUM PLC
FLMNF61.84N/A
N/A
Fielmann Group AG
RKAGY7.37N/A
N/A
Rhoen Klinikum AG